Investing.com - Aadi Bioscience (NASDAQ: AADI) reported second quarter EPS of $-0.5400, $0.15 better than the analyst estimate of $-0.6900. Revenue for the quarter came in at $6.2M versus the consensus estimate of $6.19M.
Aadi Bioscience's stock price closed at $1.40. It is down -21.3500% in the last 3 months and down -76.0300% in the last 12 months.
Aadi Bioscience saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Aadi Bioscience's stock price’s past reactions to earnings here.
According to InvestingPro, Aadi Bioscience's Financial Health score is "fair performance".
Check out Aadi Bioscience's recent earnings performance, and Aadi Bioscience's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar